Mulberrofuran A: A Multifunctional 2-Arylbenzofuran Flavonoid—Insights into Pharmacological Actions, Molecular Mechanisms, and Therapeutic Potential

Mulberrofuran A (MFA), a natural product originally isolated from the root bark of Morus alba L. (Sang-Bai-Pi), is a structurally distinctive mulberry-derived 2-arylbenzofuran bearing a prenyl-related side chain. Although MFA has attracted attention because of its phytochemical uniqueness and reported biological relevance, the available evidence specific to MFA remains limited and fragmented. In addition, pharmacological interpretations are often complicated by the frequent use of indirect evidence derived from structurally related mulberrofuran analogues, other arylbenzofurans, or complex Morus extracts. This review critically summarizes current knowledge on the chemistry, occurrence, and biological relevance of MFA, while explicitly distinguishing direct MFA-specific evidence from indirect and contextual evidence. Available studies suggest that MFA may be associated with antimicrobial activity and modulation of arachidonic acid-related inflammatory pathways, whereas its putative roles in metabolic regulation, cardiovascular protection, antiviral activity, antioxidant effects, and anticancer relevance are currently supported mainly by structurally related compounds or broader mulberry literature rather than robust MFA-specific validation. We further discuss the limitations of the current evidence base, including methodological heterogeneity, incomplete statistical reporting, the lack of pharmacokinetic and toxicity data, and the absence of clinical validation. Rather than establishing MFA as a confirmed therapeutic agent, the available literature supports its consideration as an emerging natural product candidate that warrants rigorous chemical, pharmacological, and translational investigation.